Clinical Trial Update: Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating the safety and efficacy of mesenchymal stem cell-derived extracellular vesicles to prevent bronchopulmonary dysplasia in e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• MSC-EVs (mesenchymal stem cell-derived extracellular vesicles)

Snippet

Sponsor: EXO Biologics S.A. | Conditions: Bronchopulmonary Dysplasia | Phase 1, Phase 2 | Status: RECRUITING